drugset / Trial / NCT02642523

Natriuretic Peptides and Metabolic Risk in Obesity

NCT02642523 ↗

Non-randomizedCrossoverOpen-labelOther

Summary

The investigators are examining: 1. the relationships of insulin levels and natriuretic peptide hormone levels, and 2. the effects of administering an infusion of natriuretic peptide hormone on the breakdown of fat in healthy lean and otherwise healthy obese individuals.

Timeline

Start
—
Primary completion
2017-02
Completion
2017-02

Outcome

Outcome not reported

Stopped: “Preliminary data run on rat samples showed that this study question and design would not produce conclusive results. The PI decided not to carry out the study.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic — Intravenous
Subject Nesiritide Protein / enzyme biologic 0.01 ug/kg Intravenous